Sign Up for Newsletter

Moradec LLC, founded in 2012 by Helen (Hongyuan) Mao, PhD, provides novel research tools.?The company’s novel secondary antibody-drug conjugates (2?ADCs) are used as a research tools for pre-screening antibody leads as ADC candidates.

Moradec has formed a strategic alliance with?Concortis Biosystems, a leading provider of custom toxin and linker synthesis and antibody conjugation services for developing next generation ADCs. Together, these two companies have accumulated in-depth knowledge of small molecule toxins and linkers.

11760 Sorrento Valley Rd, Suite R
San Diego, CA 92121
USAd

Web:?Moradec, LLC

Sign Up for Newsletter
Sign Up for Newsletter

Advertisement #5
Previous articleMersana
Next articleNBE Therapeutics
Sonia Portillo
Sonia Portillo is an associate editor of ADC Review | Journal of Antibody-Drug Conjugates, an online, peer reviewed publication dedicated to following the developments of ADCs and other targeted therapies and a contributing editor to Onco'Zine. Portillo studies cancer treatment from a pharmacological perspective, specifically in the area of precision and personalized medicine.